Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6411101rdf:typepubmed:Citationlld:pubmed
pubmed-article:6411101lifeskim:mentionsumls-concept:C0021246lld:lifeskim
pubmed-article:6411101lifeskim:mentionsumls-concept:C0019145lld:lifeskim
pubmed-article:6411101lifeskim:mentionsumls-concept:C0441635lld:lifeskim
pubmed-article:6411101lifeskim:mentionsumls-concept:C0004749lld:lifeskim
pubmed-article:6411101lifeskim:mentionsumls-concept:C0596577lld:lifeskim
pubmed-article:6411101lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:6411101lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:6411101lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:6411101lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:6411101lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:6411101lifeskim:mentionsumls-concept:C0304348lld:lifeskim
pubmed-article:6411101lifeskim:mentionsumls-concept:C0150312lld:lifeskim
pubmed-article:6411101pubmed:issue5lld:pubmed
pubmed-article:6411101pubmed:dateCreated1983-10-21lld:pubmed
pubmed-article:6411101pubmed:abstractTextThe aim of this work is to study the mechanism by which 4-methylesculetin (4-Me) inhibits the Ba++ induced contraction in smooth muscle. The effect of 4-Me, alone or associated with ascorbic acid, on basal tone and Ba++ induced contraction of isolated hepatic artery strips have been studied. Experiments have been carried out in the presence of lysine acetylsalicylate (LAS) and indomethacin (IN), specific inhibitors of prostaglandin-synthetase. Both LAS and IN suppressed the depressive effect of 4-Me on the Ba++ dependent contraction. Therefore, it seems reasonable to conclude that the 4-Me influence could be mediated by prostaglandins release smooth muscle.lld:pubmed
pubmed-article:6411101pubmed:languageitalld:pubmed
pubmed-article:6411101pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6411101pubmed:citationSubsetIMlld:pubmed
pubmed-article:6411101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6411101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6411101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6411101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6411101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6411101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6411101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6411101pubmed:statusMEDLINElld:pubmed
pubmed-article:6411101pubmed:monthMaylld:pubmed
pubmed-article:6411101pubmed:issn0037-8771lld:pubmed
pubmed-article:6411101pubmed:authorpubmed-author:GambaGGlld:pubmed
pubmed-article:6411101pubmed:authorpubmed-author:BettiniVVlld:pubmed
pubmed-article:6411101pubmed:authorpubmed-author:SantoniGGlld:pubmed
pubmed-article:6411101pubmed:authorpubmed-author:LegrenziEElld:pubmed
pubmed-article:6411101pubmed:authorpubmed-author:MayellaroFFlld:pubmed
pubmed-article:6411101pubmed:issnTypePrintlld:pubmed
pubmed-article:6411101pubmed:day30lld:pubmed
pubmed-article:6411101pubmed:volume59lld:pubmed
pubmed-article:6411101pubmed:ownerNLMlld:pubmed
pubmed-article:6411101pubmed:authorsCompleteYlld:pubmed
pubmed-article:6411101pubmed:pagination674-8lld:pubmed
pubmed-article:6411101pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6411101pubmed:meshHeadingpubmed-meshheading:6411101-...lld:pubmed
pubmed-article:6411101pubmed:meshHeadingpubmed-meshheading:6411101-...lld:pubmed
pubmed-article:6411101pubmed:meshHeadingpubmed-meshheading:6411101-...lld:pubmed
pubmed-article:6411101pubmed:meshHeadingpubmed-meshheading:6411101-...lld:pubmed
pubmed-article:6411101pubmed:meshHeadingpubmed-meshheading:6411101-...lld:pubmed
pubmed-article:6411101pubmed:meshHeadingpubmed-meshheading:6411101-...lld:pubmed
pubmed-article:6411101pubmed:meshHeadingpubmed-meshheading:6411101-...lld:pubmed
pubmed-article:6411101pubmed:meshHeadingpubmed-meshheading:6411101-...lld:pubmed
pubmed-article:6411101pubmed:meshHeadingpubmed-meshheading:6411101-...lld:pubmed
pubmed-article:6411101pubmed:meshHeadingpubmed-meshheading:6411101-...lld:pubmed
pubmed-article:6411101pubmed:year1983lld:pubmed
pubmed-article:6411101pubmed:articleTitle[Responses of isolated hepatic artery segments to barium in the presence of a flavonoid (4-methylesculetin), indomethacin and acetylsalicylate].lld:pubmed
pubmed-article:6411101pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6411101pubmed:publicationTypeEnglish Abstractlld:pubmed